Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Revive Therapeutics Successfully Completes Development of a Novel Lyophilized Formulation of Bucillamine
Thursday, January 11, 2024Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders is pleased to announce that it has completed
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Thursday, January 11, 2024Mirati Therapeutics Inc a commercial stage biotechnology company today announced that the European Commission granted conditional marketing authorization for KRAZATI
Arch Biopartners Receives Health Canada Approval to Conduct Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
Thursday, January 11, 2024Arch Biopartners Inc announced today that it has received a No Objection Letter from Health Canada to conduct a Phase II trial
MimiVax Announces New Investments to Support Clinical Development of SurVaxM in Glioblastoma
Wednesday, January 10, 2024MimiVax Inc a biotechnology company focused on the development of SurVaxM a survivintargeted vaccine therapy for glioblastoma and other cancers today announced new investments from the venture
GSK Enters Agreement to Acquire Aiolos Bio
Wednesday, January 10, 2024GSK plc and Aiolos Bio Inc today announced that they have entered into an agreement under which GSK will acquire Aiolos a clinicalstage biopharmaceutical company focused on addressing the unmet treatment needs of patients
AiCuris Receives €15M Milestone Payment from MSD After EMA Approval of PREVYMIS® for Kidney Transplant Recipients
Wednesday, January 10, 2024AiCuris Antiinfective Cures AG a leading clinicalstage pharmaceutical company developing novel therapeutic candidates for the prevention and treatment of severe and potentially lifethreatening infectious diseases
Atea Pharmaceuticals Reports Positive Phase 2 Data for HCV and Achieves Enrollment Milestone for COVID-19 Phase 3 Trial
Tuesday, January 09, 2024Atea Pharmaceuticals Inc a clinicalstage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases today announced the achievement of two significant clinical
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Tuesday, January 09, 2024Shuttle Pharmaceuticals Holdings Inc today announced they have received the Safe to Proceed letter from the US Food and Drug Administration for the Companys investigational new drug
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
Tuesday, January 09, 2024Merck known as MSD outside of the United States and Canada and Harpoon Therapeutics Inc today announced that the companies have entered into a definitive agreement
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
Tuesday, January 09, 2024Transgene a biotech company that designs and develops virusbased immunotherapies for the treatment of cancer and NEC Corporation a leader in IT network and AI technologies
